| Bioactivity | ATR-IN-9 is a potent inhibitor of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR) extracted from patent WO2020087170A1, compound 59, has an IC50 of 10 nM[1]. |
| Target | IC50: 10 nM (ATR) |
| Name | ATR-IN-9 |
| CAS | 2417513-43-8 |
| Formula | C22H27N7O2 |
| Molar Mass | 421.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Crane SN, et, al. Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors. WO2020087170A1. |
ATR-IN-9
CAS: 2417513-43-8 F: C22H27N7O2 W: 421.50
ATR-IN-9 is a potent inhibitor of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR) extracted from patent WO2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.